Intracoronary Injection of In Situ Forming Alginate Hydrogel Reverses Left Ventricular Remodeling After Myocardial Infarction in Swine

被引:297
作者
Leor, Jonathan [1 ]
Tuvia, Shmuel [2 ]
Guetta, Victor [1 ]
Manczur, Ferenc [3 ]
Castel, David [1 ]
Willenz, Udi [1 ]
Petnehazy, Oers [4 ]
Landa, Natali [1 ]
Feinberg, Micha S. [1 ]
Konen, Eli [5 ]
Goitein, Orly [5 ]
Tsur-Gang, Orna [6 ]
Shaul, Mazal [2 ]
Klapper, Lea [2 ]
Cohen, Smadar [6 ]
机构
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel
[2] BiolineRx, Jerusalem, Israel
[3] Szent Istvan Univ, Dept Internal Med, Fac Vet Sci, Budapest, Hungary
[4] Kaposvar Univ, Inst Diagnost Imaging & Radiat Oncol, Kaposvar, Hungary
[5] Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel
[6] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel
关键词
biomaterials; heart failure; myocardial infarction; remodeling; NEOVASCULATURE FORMATION; PDGF-BB; DELIVERY; ANGIOPLASTY; REPERFUSION; CELLS; WALL;
D O I
10.1016/j.jacc.2009.06.010
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives This study sought to determine whether alginate biomaterial can be delivered effectively into the infarcted myocardium by intracoronary injection to prevent left ventricular (LV) remodeling early after myocardial infarction (MI). Background Although injectable biomaterials can improve infarct healing and repair, the feasibility and effectiveness of intracoronary injection have not been studied. Methods We prepared a calcium cross-linked alginate solution that undergoes liquid to gel phase transition after deposition in infarcted myocardium. Anterior MI was induced in swine by transient balloon occlusion of left anterior descending coronary artery. At 4 days after MI, either alginate solution (2 or 4 ml) or saline was injected selectively into the infarct-related coronary artery. An additional group (n = 19) was treated with incremental volumes of biomaterial (1, 2, and 4 ml) or 2 ml saline and underwent serial echocardiography studies. Results Examination of hearts harvested after injection showed that the alginate crossed the infarcted leaky vessels and was deposited as hydrogel in the infarcted tissue. At 60 days, control swine experienced an increase in left ventricular (LV) diastolic area by 44%, LV systolic area by 45%, and LV mass by 35%. In contrast, intracoronary injection of alginate (2 and 4 ml) prevented and even reversed LV enlargement (p < 0.01). Post-mortem analysis showed that the biomaterial (2 ml) increased scar thickness by 53% compared with control (2.9 +/- 0.1 mm vs. 1.9 +/- 0.3 mm; p < 0.01) and was replaced by myofibroblasts and collagen. Conclusions Intracoronary injection of alginate biomaterial is feasible, safe, and effective. Our findings suggest a new percutaneous intervention to improve infarct repair and prevent adverse remodeling after reperfused MI. (J Am Coll Cardiol 2009;54:1014-23) (c) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:1014 / 1023
页数:10
相关论文
共 36 条
[1]
RADIOIODINATION OF ALGINATE VIA COVALENTLY-BOUND TYROSINAMIDE ALLOWS MONITORING OF ITS FATE IN-VIVO [J].
ALSHAMKHANI, A ;
DUNCAN, R .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1995, 10 (01) :4-13
[2]
Left ventricular remodeling after primary coronary angioplasty - Patterns of left ventricular dilation and long-term prognostic implications [J].
Bolognese, L ;
Neskovic, AN ;
Parodi, G ;
Cerisano, G ;
Buonamici, P ;
Santoro, GM ;
Antoniucci, D .
CIRCULATION, 2002, 106 (18) :2351-2357
[3]
Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution [J].
Cabrales, P ;
Tsai, AG ;
Intaglietta, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (04) :H1708-H1716
[4]
Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardiol performance in infrcted rat hearts [J].
Caspi, Oren ;
Huber, Irit ;
Kehat, Izhak ;
Habib, Manhal ;
Arbel, Gil ;
Gepstein, Amira ;
Yankelson, Lior ;
Aronson, Doron ;
Beyar, Rafael ;
Gepstein, Lior .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) :1884-1893
[5]
Biomaterials for the treatment of myocardial infarction [J].
Christman, Karen L. ;
Lee, Randall J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) :907-913
[6]
Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer [J].
Christman, KL ;
Fang, QZ ;
Yee, MS ;
Johnson, KR ;
Sievers, RE ;
Lee, RJ .
BIOMATERIALS, 2005, 26 (10) :1139-1144
[7]
Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium [J].
Christman, KL ;
Vardanian, AJ ;
Fang, QZ ;
Sievers, RE ;
Fok, HH ;
Lee, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (03) :654-660
[8]
Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling [J].
Cohn, JN ;
Ferrari, R ;
Sharpe, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :569-582
[9]
Thickening of the infarcted wall by collagen injection improves left ventricular function in rats [J].
Dai, WD ;
Wold, LE ;
Dow, JS ;
Kloner, RA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (04) :714-719
[10]
Custom design of the cardiac microenvironment with biomaterials [J].
Davis, ME ;
Hsieh, PCH ;
Grodzinsky, AJ ;
Lee, RT .
CIRCULATION RESEARCH, 2005, 97 (01) :8-15